Dr. Eric P. Winer,医学博士, 1983年毕业于耶鲁大学。1989-1997年在杜克大学医学中心血液学和肿瘤教授，并担任多学科的乳腺项目主任。1997年，他加入了Brigham and Women's Hospital和Dana-Farber担任乳腺肿瘤中心主任。Dr. Eric P. Winer现任临床程序执行委员会主席，哈佛医学院医学教授，Dana-Farber妇女癌症科主任，乳腺肿瘤中心主任，Susan F. Smith中心妇女癌症Thompson主席。他的专长是肿瘤医学。
医学博士，耶鲁大学癌症中心主任，耶鲁纽黑文斯米洛癌症医院主任医师。Winer 博士是国际知名的乳腺癌专家，其研究成果屡获殊荣，改变了疾病的面貌。他担任美国国家癌症研究所 (NCI) 乳腺癌指导委员会的联合主席，该委员会负责监督由 NCI 赞助的乳腺癌临床试验。他的指导工作也得到了认可，并于 2020 年获得了哈佛医学院颁发的 William Silen 终身指导成就奖。
Winer 博士毕业于耶鲁大学，获得历史和俄罗斯/东欧研究学位。随后，他在耶鲁大学医学院获得医学学位，随后在耶鲁大学接受内科培训。他在杜克大学医学中心完成了医学肿瘤学研究，并在杜克大学任教至 1997 年。随后，他在达纳-法伯癌症研究所、布莱根妇女医院和哈佛医学院工作了 24 年。在 2022 年返回耶鲁之前，Winer 博士担任乳腺癌研究汤普森主席，并担任 Dana-Farber 癌症研究所的首席临床开发官和医学事务高级副总裁，以及哈佛医学院的医学教授。
Dr. Eric P. Winer, 医学博士近期发表的学术论文：
Punglia RS, Kuntz KM, Winer E, Weeks JC, Burstein HJ. Optimizing adjuvant endocrine therapy in postmenopausal women with early stage breast cancer: a decision analysis. J Clin oncol 2005;23:5178-87.
Muss HB, Woolf S, Berry D, Cirrincione C, Weiss RB, Budman D, Wood WC, Henderson IC, Hudis C, Winer E, Cohen H, Wheeler J, Norton L. Adjuvant chemotherapy is equally effective for older women and younger women with lymph node-positive breast cancer: The Cancer and Leukemia Group B experience. JAMA 2005;293:1073-81.
Burstein HJ, Harris LN, Gelman R, Lester SC, Nunes RA, Kaelin CM, Parker LM, Ellisen LW, Kuter I, Gadd MA, Christian RL, Kennedy PR, Borges VF, Bunnell CA, Younger J, Smith BL, Winer EP. Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer. J Clin oncol 2003;21:46-53.
Partridge AH, Gelber S, Knudsen K, Laufer M, Rosenberg R, Przypyszny M, Rein A, Winer EP. Web-based survey of fertility issues in young women with breast cancer. J Clin oncol 2004;22:4174-83.
Keating NL, Landrum MB, Ayanian JZ, Winer EP, Guadagnoli E. The association of ambulatory care with breast cancer stage at diagnosis among Medicare beneficiaries. J Gen Intern Med 2005;20:38-44.
Partridge AH, Wang PS, Winer EP, Avorn JL. Non-adherence with adjuvant tamoxifen therapy in women with early stage-breast cancer. J Clin oncol 2003;21:602-4.
Partridge AH, Burstein HJ, Gelman RS, Marcom PK, Winer EP. Do patients participating in clinical trials want to know study results? J Natl Cancer Inst 2003;95:491-2.
Partridge AH, Wong JS, Knudsen K, Gelman R, Sampson E, Gadd M, Bishop K, Harris JR, Winer EP. Offering participants results of a clinical trial: sharing results of a negative study. Lancet 2005;365:963-4.
Harris LN, Kaelin C, Bellon JR, Winer EP. Preoperative therapy for operable breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the Breast. 3rd Edition. New York: Lippincott Williams Wilkins; 2004. p.929-43.
Partridge AH, Hackett N, Blood E, Gelman R, Joffe S, Bauer-Wu S, Knudsen K, Emmons K, Collyar D, Schilsky RL, Winer EP. oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants. J Natl Cancer Inst 2004;96:629-32.
